Industry
Drug Manufacturers - Specialty & Generic
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
August 20, 2024 | 1:57 pm
Portfolio Pulse from Benzinga Newsdesk
August 13, 2024 | 12:23 pm
Portfolio Pulse from Benzinga Newsdesk
July 31, 2024 | 11:50 pm
Portfolio Pulse from Henry Khederian
July 30, 2024 | 9:22 pm
Portfolio Pulse from Benzinga Newsdesk
July 30, 2024 | 2:29 pm
Portfolio Pulse from Benzinga Newsdesk
July 30, 2024 | 12:31 pm
Portfolio Pulse from Benzinga Newsdesk
June 17, 2024 | 12:41 pm
Portfolio Pulse from Benzinga Insights
May 23, 2024 | 8:31 pm
Portfolio Pulse from Benzinga Newsdesk
May 16, 2024 | 8:22 pm
Portfolio Pulse from Benzinga Newsdesk
May 14, 2024 | 8:55 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.